ANTABUSE Side Effects

6656939-X | Coagulopathy, Jaundice, Malaise, Mental Status Changes, Substance Abuse
on Mar 29, 2010 Female patient from UNITED STATES , 40 years of age, weighting 123.5 lb, was diagnosed with alcohol abuse and was treated with Antabuse (View Usage). Patient experienced the following unwanted or unexpected effects: coagulopathy, jaundice (What is jaundice?), malaise, mental status changes, substance abuse. Antabuse dosage: Unk Unk Oral 047. Patient was hospitalized.

6638434-7 | Abdominal Pain, Coagulopathy, Coma, Decreased Appetite, Jaundice, Liver Transplant, Malaise, Mental Status Changes
Patient was taking Antabuse (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), coagulopathy, coma, decreased appetite, jaundice (What is jaundice?), liver transplant (What is liver transplant?), malaise, mental status changes on Mar 16, 2010 from UNITED STATES Additional patient health information: Male patient , 23 years of age, weighting 196.2 lb, was diagnosed with alcohol abuse and. Antabuse dosage: 250 Mg Daily Oral 047. Patient was hospitalized.

6608007-0 | Coagulopathy, Jaundice, Malaise, Mental Status Changes
Adverse event was reported on Feb 26, 2010 by a Male patient taking Antabuse (View Usage) (Dosage: Unk Unk Oral 047) was diagnosed with alcohol abuse and. Location: UNITED STATES , 39 years of age, weighting 260.1 lb, After Antabuse was administered, patient had the following side effects: coagulopathy, jaundice (What is jaundice?), malaise, mental status changes. Patient was hospitalized.

6607994-4 | Abdominal Pain, Arthralgia, Coagulopathy, Headache, Jaundice, Malaise, Mental Status Changes
on Feb 26, 2010 Female patient from UNITED STATES , 36 years of age, weighting 145.9 lb, was diagnosed with alcohol abuse and was treated with Antabuse (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), arthralgia, coagulopathy, headache (What is headache?), jaundice (What is jaundice?), malaise, mental status changes. Antabuse dosage: Unk Daily Oral 047. Patient was hospitalized.


6477880-1 | Asthenia, Confusional State, Hypoaesthesia, Neuropathy Peripheral, Paraesthesia
on Dec 03, 2009 Female patient from UNITED STATES , 47 years of age, weighting 100.0 lb, was diagnosed with alcohol abuse and was treated with Antabuse (View Usage). Patient had the following side effects: asthenia, confusional state, hypoaesthesia, neuropathy peripheral, paraesthesia. Antabuse dosage: 250 Mg Once Daily Po.

6233862-6 | Aggression, Alcohol Intolerance, Brain Injury, Disturbance In Attention, Impaired Work Ability, Insomnia, Mental Impairment, Nasal Polyps
Patient was taking Antabuse (View Usage). After Antabuse was administered, patient had the following side effects: aggression, alcohol intolerance, brain injury, disturbance in attention, impaired work ability, insomnia, mental impairment, nasal polyps on Jun 16, 2009 from UNITED STATES Additional patient health information: Male patient , 33 years of age, weighting 200.0 lb, . Antabuse dosage: . Patient was hospitalized.

6146053-4 | Breast Pain, Breath Odour, Hyperaesthesia, Lip Blister, Oral Pain, Paraesthesia
Adverse event was reported on Apr 06, 2009 by a Female patient taking Antabuse (View Usage) (Dosage: 250 Mg Daily Po) was diagnosed with alcohol use and. Location: UNITED STATES , 63 years of age, weighting 185.0 lb, Patient experienced the following unwanted or unexpected effects: breast pain, breath odour, hyperaesthesia, lip blister, oral pain, paraesthesia.

6070442-X | Anxiety, Delusion, Dyspnoea, Fatigue, Fear, Heart Rate Increased, Hyperacusis
on Jan 23, 2009 Male patient from GERMANY , 31 years of age, was treated with Antabuse (View Usage). Patient had the following side effects: anxiety (What is anxiety?), delusion, dyspnoea, fatigue, fear, heart rate increased, hyperacusis. Antabuse dosage: 250 Mg/day,. During the same period patient was treated with COCAINE(COCAINE) (View Cocaine(cocaine) Review and Cocaine(cocaine) Label ).

6022390-9 | Hepatic Enzyme Increased, Liver Injury
on Dec 23, 2008 Female patient from UNITED STATES , 30 years of age, weighting 160.0 lb, was diagnosed with alcohol rehabilitation and was treated with Antabuse (View Usage). After Antabuse was administered, patient had the following side effects: hepatic enzyme increased, liver injury. Antabuse dosage: Mon/wed/fri Po.

5939652-3 | Acidosis, Coma, Depressed Level Of Consciousness, Dermatitis Exfoliative, Disseminated Intravascular Coagulation, Exfoliative Rash, Heart Rate Increased, Hepatic Failure, Hyperbilirubinaemia
Patient was taking Antabuse (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis, coma, depressed level of consciousness, dermatitis exfoliative, disseminated intravascular coagulation, exfoliative rash, heart rate increased, hepatic failure, hyperbilirubinaemia on Oct 30, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 160.0 lb, was diagnosed with alcoholism (What is alcoholism?) and. Antabuse dosage: 500 Mg Daily Mon, Wed, Friday Po. During the same period patient was treated with PROZAC (View Prozac Review and Prozac Label ), CYPROHEPTADINE HCL (View Cyproheptadine Hcl Review and Cyproheptadine Hcl Label ). Patient was hospitalized.

5835034-3 | Stereotypy
Adverse event was reported on Jul 22, 2008 by a Female patient taking Antabuse (View Usage) (Dosage: 200 Mg/day, Qhs,) was diagnosed with alcoholic and. Location: TAIWAN, PROVINCE OF CHINA , 39 years of age, Patient had the following side effects: stereotypy.

5778053-8 | Unevaluable Event
on Jun 17, 2008 Male patient from UNITED STATES , 30 years of age, weighting 212.0 lb, was treated with Antabuse (View Usage). After Antabuse was administered, patient had the following side effects: unevaluable event. Antabuse dosage: 250 3 Times Weekly Po.

5730347-8 | Abnormal Behaviour, Delusion, Elevated Mood, Flight Of Ideas, Insomnia, Irritability, Mania, Poverty Of Speech, Psychomotor Hyperactivity
on Apr 16, 2008 Male patient from TAIWAN, PROVINCE OF CHINA , 38 years of age, was diagnosed with alcohol use and was treated with Antabuse (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, delusion, elevated mood, flight of ideas, insomnia, irritability, mania, poverty of speech, psychomotor hyperactivity. Antabuse dosage: 200 Mg, Qd; 200 Mg, Qod. Patient was hospitalized.

5728313-1 | Adverse Event
Patient was taking Antabuse (View Usage). Patient had the following side effects: adverse event on May 02, 2008 from UNITED STATES Additional patient health information: Male patient , 30 years of age, weighting 210.0 lb, . Antabuse dosage: 250mg 3 Times Weekly (duration: Over 4 Years).

5675969-8 | Activities Of Daily Living Impaired, Akathisia, Asthenia, Balance Disorder, Dysstasia, Gait Disturbance, Hypoaesthesia, Polyneuropathy
Adverse event was reported on Mar 13, 2008 by a Female patient taking Antabuse (View Usage) (Dosage: 250 Mg Bid Oral) was diagnosed with alcoholism (What is alcoholism?) and. Location: UNITED STATES , 40 years of age, weighting 100.1 lb, After Antabuse was administered, patient had the following side effects: activities of daily living impaired, akathisia, asthenia, balance disorder, dysstasia, gait disturbance, hypoaesthesia, polyneuropathy. During the same period patient was treated with SEROQUEL (View Seroquel Review and Seroquel Label ), THYROXIN T3 (LEVOTHYROXINE SODIUM, LIOTHYRONINE) (View Thyroxin T3 (levothyroxine Sodium, Liothyronine) Review and Thyroxin T3 (levothyroxine Sodium, Liothyronine) Label ).

5625823-2 | Acute Hepatic Failure, Blood Alcohol Increased, Encephalopathy, Haemodialysis, Hepatomegaly, Hypotension, Renal Failure, Thrombocytopenia
on Jan 29, 2008 Male patient from GERMANY , 35 years of age, was diagnosed with alcoholism (What is alcoholism?) and was treated with Antabuse (View Usage). Patient experienced the following unwanted or unexpected effects: acute hepatic failure, blood alcohol increased, encephalopathy, haemodialysis, hepatomegaly, hypotension, renal failure, thrombocytopenia. Antabuse dosage: Implant. Patient was hospitalized.

5623782-X | Akathisia, Asthenia, Balance Disorder, Dysstasia, Gait Disturbance, Hypoaesthesia, Polyneuropathy
on Feb 21, 2007 Female patient from UNITED STATES , 40 years of age, weighting 100.3 lb, was diagnosed with alcoholism (What is alcoholism?) and was treated with Antabuse (View Usage). Patient had the following side effects: akathisia, asthenia, balance disorder, dysstasia, gait disturbance, hypoaesthesia, polyneuropathy. Antabuse dosage: 250 Mg, Bid; Oral. During the same period patient was treated with SEROQUEL (View Seroquel Review and Seroquel Label ), THYROXIN T3 (LEVOTHYROXINE SODIUM, LIOTHYRONINE) (View Thyroxin T3 (levothyroxine Sodium, Liothyronine) Review and Thyroxin T3 (levothyroxine Sodium, Liothyronine) Label ).

5585262-X | Hepatic Infiltration Eosinophilic, Hepatitis Acute, Hepatocellular Injury, Liver Injury
Patient was taking Antabuse (View Usage). After Antabuse was administered, patient had the following side effects: hepatic infiltration eosinophilic, hepatitis acute, hepatocellular injury, liver injury on Jan 08, 2008 from UNITED STATES Additional patient health information: Female patient , 43 years of age, . Antabuse dosage: .

5575545-1 | Headache, Hypoaesthesia, Neuropathy Peripheral, Optic Neuropathy, Paraesthesia, Visual Acuity Reduced
Adverse event was reported on Dec 11, 2007 by a Male patient taking Antabuse (View Usage) (Dosage: Oral) was diagnosed with alcoholism (What is alcoholism?) and. Location: IRELAND , 57 years of age, Patient experienced the following unwanted or unexpected effects: headache (What is headache?), hypoaesthesia, neuropathy peripheral, optic neuropathy, paraesthesia, visual acuity reduced. During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ). Patient was hospitalized.

5570044-5 | Bradyphrenia, Cerebral Atrophy, Coma, Delirium, Disorientation, Encephalopathy, Grand Mal Convulsion, Oxygen Saturation Decreased, Pneumonia Aspiration
on Nov 30, 2007 Male patient from SPAIN , 40 years of age, was diagnosed with alcoholism (What is alcoholism?) and was treated with Antabuse (View Usage). Patient had the following side effects: bradyphrenia, cerebral atrophy, coma, delirium, disorientation, encephalopathy, grand mal convulsion, oxygen saturation decreased, pneumonia aspiration. Antabuse dosage: 250 Mg, Qd, Oral. During the same period patient was treated with FOSAMPRENAVIR (View Fosamprenavir Review and Fosamprenavir Label ), TENOFOVIR (TENOFOVIR) (View Tenofovir (tenofovir) Review and Tenofovir (tenofovir) Label ), EMTRICITABINE (EMTRICITABINE) (View Emtricitabine (emtricitabine) Review and Emtricitabine (emtricitabine) Label ). Patient was hospitalized.

5500168-X | Agitation, Alcohol Interaction, Anxiety, Blood Alcohol Increased, Hot Flush, Hypotension, Restlessness, Sinus Tachycardia, Tremor
on Oct 16, 2007 Male patient from TAIWAN, PROVINCE OF CHINA , 35 years of age, was diagnosed with alcoholism (What is alcoholism?) and was treated with Antabuse (View Usage). After Antabuse was administered, patient had the following side effects: agitation, alcohol interaction, anxiety (What is anxiety?), blood alcohol increased, hot flush, hypotension, restlessness, sinus tachycardia, tremor. Antabuse dosage: 400 Mg, Qd.

5402774-X | Alcohol Intolerance, Delusion, Disturbance In Attention, Dyspnoea, Flushing, Hallucination, Auditory, Headache, Insomnia, Logorrhoea
Patient was taking Antabuse (View Usage). Patient experienced the following unwanted or unexpected effects: alcohol intolerance, delusion, disturbance in attention, dyspnoea, flushing, hallucination, auditory, headache (What is headache?), insomnia, logorrhoea on Jul 18, 2007 from TURKEY Additional patient health information: Male patient , 34 years of age, was diagnosed with alcoholism (What is alcoholism?) and. Antabuse dosage: 500 Mg/day, Oral, 1500 Mg/day; Oral. During the same period patient was treated with ALCOHOL (ETHANOL) (3 Units,) (View Alcohol (ethanol) Review and Alcohol (ethanol) Label ). Patient was hospitalized.

5402773-8 | Alcohol Intolerance, Dizziness, Electrocardiogram St Segment Depression, Flushing, Hyperhidrosis, Hypotension, No Therapeutic Response, Palpitations, Sinus Tachycardia
Adverse event was reported on Jul 18, 2007 by a Male patient taking Antabuse (View Usage) (Dosage: Oral) was diagnosed with alcoholism (What is alcoholism?) and. Location: UNITED KINGDOM , 27 years of age, Patient had the following side effects: alcohol intolerance, dizziness (What is dizziness?), electrocardiogram st segment depression, flushing, hyperhidrosis, hypotension, no therapeutic response, palpitations, sinus tachycardia. During the same period patient was treated with ALCOHOL (ETANOL) (Oral) (View Alcohol (etanol) Review and Alcohol (etanol) Label ). Patient was hospitalized.

5324714-4 | Akinesia, Alanine Aminotransferase Increased, Anaemia, Areflexia, Aspartate Aminotransferase Increased, Asthenia, Blepharospasm, Bradyphrenia, Cerebellar Ataxia
on Apr 23, 2007 Male patient from FRANCE , 41 years of age, was treated with Antabuse (View Usage). After Antabuse was administered, patient had the following side effects: akinesia, alanine aminotransferase increased, anaemia, areflexia, aspartate aminotransferase increased, asthenia, blepharospasm, bradyphrenia, cerebellar ataxia. Antabuse dosage: 500 Mg, Qd, Unk. Patient was hospitalized.

5324499-1 | Akinesia, Alanine Aminotransferase Increased, Amnesia, Anaemia, Areflexia, Aspartate Aminotransferase Increased, Asthenia, Blepharospasm, Cerebellar Ataxia
on Apr 23, 2007 Male patient from FRANCE , 41 years of age, was treated with Antabuse (View Usage). Patient experienced the following unwanted or unexpected effects: akinesia, alanine aminotransferase increased, amnesia, anaemia, areflexia, aspartate aminotransferase increased, asthenia, blepharospasm, cerebellar ataxia. Antabuse dosage: 500 Mg, Qd. Patient was hospitalized.

5318717-3 | Alanine Aminotransferase Increased, Altered State Of Consciousness, Aspartate Aminotransferase Increased, Asthenia, Blood Pressure Increased, Cerebral Atrophy, Confusional State, Coordination Abnormal, Delirium
Patient was taking Antabuse (View Usage). Patient had the following side effects: alanine aminotransferase increased, altered state of consciousness, aspartate aminotransferase increased, asthenia, blood pressure increased, cerebral atrophy, confusional state, coordination abnormal, delirium on Apr 20, 2007 from JAPAN Additional patient health information: Male patient , 50 years of age, was diagnosed with alcoholism (What is alcoholism?) and. Antabuse dosage: See Image. During the same period patient was treated with ETHYL LOFLAZEPATE (ETYL LOFLAZEPATE) (3 Mg/day) (View Ethyl Loflazepate (etyl Loflazepate) Review and Ethyl Loflazepate (etyl Loflazepate) Label ), IFENPRODIL TARTRATE(IFENPRODIL TARTRATE) (60 Mg/day) (View Ifenprodil Tartrate(ifenprodil Tartrate) Review and Ifenprodil Tartrate(ifenprodil Tartrate) Label ), CYANAMIDE(CALCICUM CARBIMIDE) (70 Mg) (View Cyanamide(calcicum Carbimide) Review and Cyanamide(calcicum Carbimide) Label ). Patient was hospitalized.

5306387-X | Blepharospasm, Confusional State, Coordination Abnormal, Ophthalmoplegia, Parkinsonism, Wernicke's Encephalopathy
Adverse event was reported on Apr 04, 2007 by a Male patient taking Antabuse (View Usage) (Dosage: ) . Location: FRANCE , 41 years of age, After Antabuse was administered, patient had the following side effects: blepharospasm, confusional state, coordination abnormal, ophthalmoplegia, parkinsonism, wernicke's encephalopathy.

5306386-8 | Delirium, Delusion, Disorientation, Judgement Impaired, Memory Impairment
on Apr 04, 2007 Male patient from JAPAN , 50 years of age, was diagnosed with alcoholism (What is alcoholism?) and was treated with Antabuse (View Usage). Patient experienced the following unwanted or unexpected effects: delirium, delusion, disorientation, judgement impaired, memory impairment. Antabuse dosage: 200 Mg/day.

5268361-1 | Abnormal Behaviour, Coordination Abnormal, Dysarthria, Dysstasia, Gait Disturbance
on Mar 05, 2007 Male patient from UNITED STATES , 31 years of age, weighting 187.0 lb, was diagnosed with alcoholism (What is alcoholism?) and was treated with Antabuse (View Usage). Patient had the following side effects: abnormal behaviour, coordination abnormal, dysarthria, dysstasia, gait disturbance. Antabuse dosage: 250 Mg, Qd, Unk. During the same period patient was treated with CAMPRAL (666 Mg, Tid, Unk) (View Campral Review and Campral Label ), EFFEXOR (View Effexor Review and Effexor Label ).

5259450-6 | Akathisia, Asthenia, Balance Disorder, Dysstasia, Gait Disturbance, Hypoaesthesia, Polyneuropathy
Patient was taking Antabuse (View Usage). After Antabuse was administered, patient had the following side effects: akathisia, asthenia, balance disorder, dysstasia, gait disturbance, hypoaesthesia, polyneuropathy on Feb 21, 2007 from UNITED STATES Additional patient health information: Female patient , 40 years of age, weighting 100.1 lb, was diagnosed with alcoholism (What is alcoholism?) and. Antabuse dosage: 250 Mg, Bid, Oral. During the same period patient was treated with SEROQUEL (View Seroquel Review and Seroquel Label ), THYROXIN T3 (LEVOTHYROXINE SODIUM, LIOTHYRONINE) (View Thyroxin T3 (levothyroxine Sodium, Liothyronine) Review and Thyroxin T3 (levothyroxine Sodium, Liothyronine) Label ).

5248617-9 | Abdominal Pain Upper, Antinuclear Antibody Positive, Coagulation Factor V Level Decreased, Coagulopathy, Hepatic Encephalopathy, Hepatic Failure, Hepatic Function Abnormal, Hepatic Necrosis, Jaundice
Adverse event was reported on Feb 06, 2007 by a Female patient taking Antabuse (View Usage) (Dosage: 500 Mg, 2/week, Unk) was diagnosed with alcoholism (What is alcoholism?) and. Location: UNITED STATES , 16 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain upper, antinuclear antibody positive, coagulation factor v level decreased, coagulopathy, hepatic encephalopathy, hepatic failure, hepatic function abnormal, hepatic necrosis, jaundice (What is jaundice?). Patient was hospitalized.

5247668-8 | Acute Hepatic Failure, Blood Alcohol Increased, Blood Lactic Acid Increased, Coagulopathy, Encephalopathy, Foetor Hepaticus, Haemodialysis, Hypotension, Oedema Due To Hepatic Disease
on Feb 06, 2007 Male patient from GERMANY , 35 years of age, was diagnosed with alcoholism (What is alcoholism?) and was treated with Antabuse (View Usage). Patient had the following side effects: acute hepatic failure, blood alcohol increased, blood lactic acid increased, coagulopathy, encephalopathy, foetor hepaticus, haemodialysis, hypotension, oedema due to hepatic disease. Antabuse dosage: Implant. Patient was hospitalized.

5137043-9 | Hepatic Trauma, Hepatitis Acute, Hyponatraemia, Leukopenia, Myalgia, Renal Failure Acute, Renal Tubular Necrosis, Thrombocytopenia
on Oct 24, 2006 Female patient from UNITED STATES , 44 years of age, was treated with Antabuse (View Usage). After Antabuse was administered, patient had the following side effects: hepatic trauma, hepatitis acute, hyponatraemia, leukopenia, myalgia, renal failure acute, renal tubular necrosis, thrombocytopenia. Antabuse dosage: . During the same period patient was treated with DISULFIRAM (View Disulfiram Review and Disulfiram Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), EFFEXOR (View Effexor Review and Effexor Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), EXTRA STRENGTH TYLENOL (View Extra Strength Tylenol Review and Extra Strength Tylenol Label ). Patient was hospitalized.